Benzinga - Fri, 15 Jan 2021 06:49:42 -0400
Benzinga - Wed, 06 Jan 2021 10:20:00 -0400
Benzinga - Fri, 11 Dec 2020 06:01:01 -0400
Benzinga - Thu, 29 Oct 2020 16:00:38 -0400
Benzinga - Thu, 29 Oct 2020 04:08:21 -0400
load more
Sector: Health Care.Industry: Biotechnology
Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves three small molecule drug candidates namely LP-100, LP-184, and LP-300.

Earnings

see more
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-02-12
REV
Q3 2020Est.ActualSurprise
EPS-0.330-0.270 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
LTRNLantern Pharma0.28%89.2M

Lantern Pharma Company Questions & Answers

Q

How do I buy Lantern Pharma (LTRN) stock?

A

You can purchase shares of Lantern Pharma (NASDAQ: LTRN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lantern Pharma's (LTRN) main competitors?

A

Other companies in Lantern Pharma’s space includes: PolarityTE (NASDAQ:PTE), Cellectar Biosciences (NASDAQ:CLRB) and Monopar Therapeutics (NASDAQ:MNPR).

Q

What is the target price for Lantern Pharma?

A

The latest price target for Lantern Pharma (NASDAQ: LTRN) was reported by Colliers Securities on 2020-07-28. The analyst firm set a price target for 24.00 expecting LTRN to rise to within 12 months (a possible 67.36% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Lantern Pharma (LTRN) stock ?

A

The stock price for Lantern Pharma (NASDAQ: LTRN) is $14.34 last updated Fri Jan 15 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Lantern Pharma (LTRN) dividend?

A

There are no upcoming dividends for Lantern Pharma.

Q

When is Lantern Pharma (NASDAQ:LTRN) reporting earnings?

A
Lantern Pharma’s Q4 earnings are confirmed after-market from now on February 12, 2021.
Q

When is the upcoming split for LTRN?

A

There is no upcoming split for Lantern Pharma.